|
Market Closed -
Nasdaq
01:30:00 29/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.020 USD | -3.35% |
|
-3.35% | +47.45% |
| 13/08 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 13/08 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
| Market Cap | 70Cr 60Cr 56Cr 51Cr 97Cr 6.67TCr 97Cr 668.96Cr 261Cr 3.37TCr 262.02Cr 256.32Cr 11TCr | P/E 2026 * |
-3.35x | P/E 2027 * | -3.15x |
|---|---|---|---|---|---|
| Enterprise Value | 50Cr 43Cr 41Cr 37Cr 70Cr 4.79TCr 70Cr 480.58Cr 187.51Cr 2.42TCr 188.24Cr 184.14Cr 8.02TCr | EV / Sales 2026 * |
147x | EV / Sales 2027 * | 45.3x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Allogene Therapeutics, Inc.
| 1 day | -3.35% | ||
| 1 week | -3.35% | ||
| Current month | +7.45% | ||
| 1 month | +11.60% | ||
| 3 months | -6.91% | ||
| 6 months | -27.34% | ||
| Current year | +47.45% |
| 1 week | 2 |  | 2.21 |
| 1 month | 1.81 | | 2.23 |
| Current year | 1.31 | | 4.46 |
| 1 year | 1.04 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
David Chang
BRD | Director/Board Member | 66 | 01/06/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/08/26 | Sell | Compliance Officer | -29,697 | 0.0086% | ||
| 01/07/26 | Free | Chief Executive Officer | 6,10,720 | 0.1769% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.35% | -3.35% | +78.76% | -47.40% | 70Cr | |
| -1.59% | -3.35% | +52.37% | +93.70% | 6.95TCr | |
| -1.34% | -0.75% | +48.21% | +91.86% | 6.5TCr | |
| +0.30% | -0.69% | +52.56% | +10.23% | 2.65TCr | |
| -2.35% | -5.75% | -12.90% | +448.54% | 2.59TCr | |
| -8.37% | -12.43% | +2.08% | -16.71% | 2.56TCr | |
| -0.96% | +10.36% | +283.06% | +436.50% | 2.02TCr | |
| -0.51% | +0.23% | +35.77% | -18.70% | 2TCr | |
| -1.91% | -4.37% | +13.28% | +535.19% | 1.57TCr | |
| -1.47% | +0.68% | +45.51% | +143.08% | 1.35TCr | |
| Average | -2.16% | -2.07% | +59.87% | +167.63% | 2.83TCr | |
| Weighted average by Cap. | -1.93% | -1.51% | +53.79% | +151.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34L 29.3L 27.47L 25.08L 47.24L 32Cr 47.39L 3.26Cr 1.27Cr 16Cr 1.28Cr 1.25Cr 54Cr | 1.21Cr 1.04Cr 97.64L 89.14L 1.68Cr 115.51Cr 1.68Cr 12Cr 4.52Cr 58Cr 4.54Cr 4.44Cr 193.34Cr |
| Net income | -19Cr -16Cr -15Cr -14Cr -26Cr -1.77TCr -26Cr -177.47Cr -69Cr -893.22Cr -70Cr -68Cr -2.96TCr | -22Cr -19Cr -18Cr -16Cr -31Cr -2.1TCr -31Cr -210.72Cr -82Cr -1.06TCr -83Cr -81Cr -3.52TCr |
| Net Debt | -20Cr -17Cr -16Cr -14Cr -27Cr -1.88TCr -27Cr -188.38Cr -73Cr -948.13Cr -74Cr -72Cr -3.14TCr | -15Cr -13Cr -12Cr -11Cr -21Cr -1.44TCr -21Cr -143.94Cr -56Cr -724.5Cr -56Cr -55Cr -2.4TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $2.020 | -3.35% | 38,24,689 |
| 27/26/27 | $2.090 | +2.45% | 49,82,882 |
| 26/26/26 | $2.040 | -5.99% | 50,20,715 |
| 25/26/25 | $2.170 | +6.90% | 61,56,769 |
| 24/26/24 | $2.030 | -2.87% | 47,55,951 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
